eli lilly glp 1 agonist GLP-1 Competitive Environment Medscape | Orforglipron, Eli Lilly's
Description
Gastrointestinal symptoms dominate
This means food stays in the stomach longer than it should
2025 Apr 2;10(6):1980-1992
& Anania, F
A randomized non-inferiority study comparing the addition of exenatide twice daily to sitagliptin or switching from sitagliptin to exenatide twice daily in patients with type 2 diabetes experiencing inadequate glycaemic control on metformin and sitagliptin
However, few research has explored its role on generating GLP-1 of islet cell
